index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau

Dernières publications

Chiffres clés

122 Publications avec texte intégral
1 Données de recherche

Open Access

48 %

Mots clés

BVES Laminopathies Treatment delay C elegans Regeneration Dilated cardiomyopathy AAV VECTOR Dynamin 2 GNE Lamins COL1A1 Centronuclear myopathy Lamin A/C LMNA gene Cancer biomarkers POPDC1 Myopathies Myotubes Dystrophine Myologie Cardiac conduction system Mouse Myogenesis Autophagosome maturation Biological sciences A-type lamin Hypermobile EDS Laminopathie Cardiology AAV Muscle Lamin A/C Therapy Diagnosis Dystrophie musculaire Connective tissue LMNA gene Duchenne muscular dystrophy Next generation sequencing Allele-specific silencing Neuromuscular diseases RNA interference LMNA-related congenital muscular dystrophy Patient registry Rare neuromuscular diseases Butyrylcholinesterase COL6A1 Acetyltransferase Heart Muscle MRI Errance diagnostique Adult SMA Base de données FAIR Heart failure Maladies rares et orphelines Titin COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Myopathy Muscle biopsy Rare diseases CRISPR Laminopathy Cardiomyopathy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Alternative splicing INPP5K CSF protein LMNA Actionability A-type lamins Nuclear envelope Mutations Actionable gene Allele‐specific silencing therapy Becker muscular dystrophy Emerin Joint laxity Exome Clinical trial Allele-specific silencing therapy LGMD C2C12 IPSC Calcium handling CMTX Muscular dystrophy MD Skeletal muscle Ehlers‐Danlos Syndrome Muscular dystrophy Biomarker Maladies rares Treatment Cancer Angiotensin-converting enzyme inhibitor Gene therapy Lamin A/C nuclei Angiotensin-converting enzyme inhibitors COVID-19 Emery-Dreifuss muscular dystrophy Congenital muscular dystrophy BiP